# Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease

> **NCT07022080** · NA · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 69 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases (IBD)

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-grazytracer PET/CT Scan

## Key facts

- **NCT ID:** NCT07022080
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07022080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07022080, "Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07022080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*